Structure Therapeutics Inc (GPCR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GPCR | AMGN | VRTX | REGN | GSK |
| Company | Structure Therapeutics Inc | Amgen Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals | Gsk Plc ADR |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NYSE |
| Open | 35.45 | 306.79 | 455.00 | 980.16 | 41.22 |
| High | 59.77 | 311.48 | 471.39 | 1,001.04 | 41.72 |
| Low | 33.56 | 304.21 | 453.73 | 979.26 | 40.52 |
| Last | 57.27 | 304.43 | 465.00 | 990.40 | 40.85 |
| Change | +23.07 | -1.42 | +9.66 | +10.24 | -3.92 |
| % Change | +67.46% | -0.46% | +2.12% | +1.04% | -8.76% |
| Volume | 8,123,689 | 1,069,207 | 881,272 | 305,041 | 7,909,538 |
| 20-Day Average Volume | 871,602 | 2,521,283 | 1,203,206 | 376,752 | 3,650,209 |
| Previous Close | 34.20 | 305.85 | 455.34 | 980.16 | 44.77 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 37.71 | 307.79 | 437.50 | 976.48 | 44.54 |
| 20-Day Raw Stochastic | 89.36% | 36.92% | 91.97% | 84.05% | 0.46% |
| 20-Day Relative Strength | 75.25% | 56.06% | 70.38% | 60.54% | 37.62% |
| Weighted Alpha | +11.96 | +34.71 | +41.93 | +32.88 | +14.30 |
| Today's Opinion | 16% Sell | 72% Buy | 88% Buy | 88% Buy | 48% Buy |
| Previous Opinion | 100% Sell | 72% Buy | 88% Buy | 88% Buy | 100% Buy |
| Last Month's Opinion | 88% Sell | 16% Sell | 8% Buy | 48% Buy | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +53.80% since 05/24/24 | -0.25% since 05/24/24 | +1.80% since 05/24/24 | +0.80% since 05/24/24 | -10.10% since 05/24/24 |
| Low | 33.74 on 05/30/24 | 295.49 on 05/30/24 | 435.57 on 05/30/24 | 952.30 on 05/30/24 | 40.54 on 06/03/24 |
| High | 59.77 on 06/03/24 | 311.41 on 06/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.01 on 05/31/24 |
| 1-Month | |||||
| %Chg | +45.08% since 05/03/24 | -2.00% since 05/03/24 | +15.98% since 05/03/24 | +3.76% since 05/03/24 | -6.75% since 05/03/24 |
| Low | 33.74 on 05/30/24 | 295.49 on 05/30/24 | 394.03 on 05/07/24 | 950.27 on 05/06/24 | 40.54 on 06/03/24 |
| High | 59.77 on 06/03/24 | 321.44 on 05/15/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 3-Month | |||||
| %Chg | +38.22% since 03/01/24 | +8.83% since 03/01/24 | +7.49% since 03/01/24 | +1.03% since 03/01/24 | -3.49% since 03/01/24 |
| Low | 33.65 on 03/14/24 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 | 39.15 on 04/18/24 |
| High | 59.77 on 06/03/24 | 322.60 on 05/03/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| 6-Month | |||||
| %Chg | -4.31% since 12/01/23 | +11.97% since 12/01/23 | +32.47% since 12/01/23 | +21.85% since 12/01/23 | +10.92% since 12/01/23 |
| Low | 26.61 on 12/18/23 | 260.68 on 04/19/24 | 347.51 on 12/04/23 | 802.55 on 12/04/23 | 35.81 on 12/07/23 |
| High | 66.38 on 12/04/23 | 329.72 on 02/05/24 | 471.39 on 06/03/24 | 1,001.04 on 06/03/24 | 45.92 on 05/15/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,594,438 | 164,068,656 | 117,501,856 | 107,999,904 | 92,783,136 |
| Shares Outstanding, K | 46,621 | 536,435 | 258,053 | 110,186 | 2,072,440 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 13,117,200,000 | 37,725,000,000 |
| Annual Net Income | -89,620,000 | 6,717,000,000 | 3,619,600,000 | 3,953,600,000 | 6,129,940,000 |
| Last Quarter Sales | 0 | 7,447,000,000 | 2,690,600,000 | 3,145,000,000 | 9,337,020,000 |
| Last Quarter Net Income | -26,040,000 | -113,000,000 | 1,099,600,000 | 722,000,000 | 1,326,430,000 |
| 60-Month Beta | N/A | 0.60 | 0.39 | 0.17 | 0.65 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.19 on 05/09/24 | 3.96 on 05/02/24 | 4.76 on 05/06/24 | 9.55 on 05/02/24 | 1.09 on 05/01/24 |
| Latest Earnings Date | 05/09/24 | 05/02/24 | 05/06/24 | 05/02/24 | 07/24/24 |
| Most Recent Dividend | N/A | 2.250 on 05/16/24 | N/A | N/A | 0.369 on 05/16/24 |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | N/A | 05/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.16 | 29.42 | 26.14 | 10.90 |